INSM Q4 2018 Earnings — Insmed Incorporated Revenue & Financial Results | Market Cap Arena

INSMInsmed Incorporated

$30B

Q4 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$10M

Gross Profit

$00.0% margin

Operating Income

-$88M-891.9% margin

Net Income

-$92M-931.1% margin

EPS (Diluted)

$-1.19

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$70M

Free Cash Flow

-$74M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$605M

Total Liabilities

$396M

Stockholders' Equity

$208M

Cash & Equivalents

$495M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$0	—
Gross Profit	$0	$0	—
Operating Income	-$88M	-$65M	-34.2%
Net Income	-$92M	-$65M	-40.1%